You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),

Recruiting
  • Metastatic Neoplasm to the Spine
  • Metastatic Neoplasm
  • Conventional external beam radiation therapy dose (EBRT)
  • +2 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 24, 2023

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023

Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

Recruiting
  • Myeloproliferative Neoplasm
  • Fedratinib Pill
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

Pancreatic Tumors, Periampullary Carcinoma Trial in Cleveland (other, dietary supplement, behavioral)

Enrolling by invitation
  • Pancreatic Neoplasms
  • Periampullary Carcinoma
  • Exercise
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cance
Aug 3, 2022

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.

Recruiting
  • Ampullary Adenoma
  • +3 more
  • Endoscopic Papillectomy
  • Forlì, Forlì-Cesena, Italy
    Ospedale Morgagni-Pierantoni
Jan 20, 2023

Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory Chronic Myelomonocytic Leukemia, Relapsed or Refractory

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
  • +1 more
Mar 14, 2023

Colorectal Cancer, Colorectal Tumors, Colorectal Adenoma Trial in Shatin (EMR or ESD)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • EMR or ESD
  • Shatin, New Territories, Hong Kong
    Prince of Wales Hospital
Dec 15, 2022

True Exocrine Epithelial Pancreatic Cystic Neoplasms Based on

Completed
  • Pancreas Cancer
  • surgical resection
  • (no location specified)
Apr 22, 2022

Pattern and Surgical Treatment of Parotid Gland Neoplasms

Recruiting
  • Parotid Gland Neoplasm
    • Sohag, Egypt
      Faculty of Medicine Sohag University
    Aug 16, 2022

    Advanced Tumors Trial in Glasgow, Manchester, Sutton (E7386)

    Recruiting
    • Advanced Neoplasms
    • Glasgow, Lanarkshire, United Kingdom
    • +2 more
    Nov 30, 2022

    CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • +6 more
    • B7-H3-CAR T cells
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 18, 2023

    Mature B-cell Tumors Trial (Nemtabrutinib)

    Not yet recruiting
    • Mature B-cell Neoplasms
    • (no location specified)
    Jan 13, 2023

    Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

    Not yet recruiting
    • Myelofibrosis (PMF)
    • +2 more
    • New York, New York
      Ruttenberg Treatment Center
    Apr 18, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

    Suspended
    • Lymphoma
    • +3 more
    • Chicago, Illinois
    • +3 more
    Jan 30, 2023

    Genetic Predisposition Testing Program for Pancreatic

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Hereditary Cancer Panel
    • Los Angeles, California
    • +2 more
    Feb 17, 2023

    Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

    Recruiting
    • Neoplasms
    • +13 more
    • HTL0039732 Capsules
    • HTL0039732 Capsules and atezolizumab infusion
    • Cambridge, United Kingdom
    • +4 more
    Jul 5, 2023

    Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

    Recruiting
    • Neuroendocrine Tumors
    • Carcinoma, Neuroendocrine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      The Endothelial Cell Dysfunction and Outcome Project for

      Not yet recruiting
      • Hematological Neoplasm
      • Endothelial Dysfunction
      • Sublingual in vivo microscopy with the Glycocheck microscope
      • (no location specified)
      Aug 14, 2022

      Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

      Recruiting
      • Neuroendocrine Tumors
      • Innsbruck, Austria
      • +2 more
      May 12, 2023

      CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

      Available
      • Central Nervous System/Leptomeningeal Neoplasms
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 15, 2022

      Early Detection of Pancreatic Cystic Neoplasms

      Recruiting
      • Pancreatic Cysts
      • +4 more
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Jul 7, 2022

        MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

        Recruiting
        • Myelodysplastic Syndromes
        • +2 more
        • Tampa, Florida
          Moffitt Cancer Center
        Feb 16, 2023